bufalin has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, A; Nie, L; Pan, L; Tan, Z; Wu, Y; Wu, Z; Yao, S; Ye, Y | 1 |
| Ge, Y; Jiang, F; Liu, C; Liu, Z; Tao, J; Xu, J; Xu, K; Yin, P; Zhu, Y | 1 |
2 other study(ies) available for bufalin and Neuroblastoma
| Article | Year |
|---|---|
Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species‑mediated apoptosis by targeting the electron transport chain.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Electron Transport; Humans; Male; Mice, Nude; Mitochondria; Neuroblastoma; Proteomics; Reactive Oxygen Species | 2020 |
Modulatory effects of bufalin, an active ingredient from toad venom on voltage-gated sodium channels.
Topics: Amphibian Venoms; Animals; Bufanolides; China; Ganglia, Spinal; HEK293 Cells; Humans; Male; Neuroblastoma; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2018 |